Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant - Summary - MDSpire
Advertisement
Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant
To present a case of pleuropulmonary blastoma (PPB) misdiagnosed as embryonal rhabdomyosarcoma and highlight the critical role of accurate diagnosis and genetic testing in guiding treatment and family counseling.
Key Findings:
Initial biopsy misinterpreted the tumor as embryonal rhabdomyosarcoma, leading to inappropriate treatment.
Definitive resection pathology established the diagnosis of PPB type III, necessitating a change in management strategy.
A pathogenic DICER1 variant was detected, highlighting the genetic implications of PPB and the need for family genetic counseling.
Interpretation:
The case emphasizes the need for accurate tissue sampling and expert pathology review to avoid misdiagnosis, which can lead to significant treatment delays and complications.
Limitations:
Germline status of the DICER1 mutation was not confirmed, which may affect family risk assessment.
Initial limited biopsy material may have contributed to misdiagnosis, underscoring the importance of adequate sampling.
Conclusion:
PPB should be prioritized in differential diagnoses for aggressive pediatric thoracic masses, and early integration of molecular testing is crucial for appropriate management and genetic counseling.
